NUVA - ニュ―ベイシブ （NuVasive Inc.）

NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ETCompany ParticipantsJuliet Cunningham - Vice President, Investor RelationsChris Barry - Chief…

NuVasive (NASDAQ: NUVA ) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings NuVasive beat estimated earnings by 9.3%, reporting an EPS of $0.47 versus an … Full story available on Benzinga.com

NuVasive press release (NUVA): Q1 Non-GAAP EPS of $0.47 beats by $0.05.Revenue of $307.7M (+5.8% Y/Y) beats by $9.26M.The Company continues to expect 2023 net sales growth of 6%ꟷ8%…

WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$1.01 million in Q1 vs. $19.20 million in the same period last year. EPS: -$0.02 in Q1 vs. $0.35 in th…

Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc SAN DIEGO, May 10, 2023 /PRNewswire/ -- NuVasive, Inc….

SAN DIEGO, May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on…

Globus Medical caught the headlines after announcing the NuVasive merger. Check out why I reiterate GMED stock as a long-term buy.

When the merger closes, Globus shareholders will own about 72% of the combined company.

AUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive (NASDAQ: NUVA ). As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction. "Globus Medical shareholders showed an overwhelming level of support for this merger," said Dan Scavilla, president and CEO of Globus Medical. "Globus Medical and NuVasive are committed to providing innovative technologies and industry leading clinical support to help surgeons and healthcare providers deliver continually improving care. Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients.

NuVasive (NUVA) shareholders have approved the company''s planned merger with Globus Medical (GMED). Read more here.

NuVasive''s XLIF and ALIF spine surgery procedures will drive its revenue and profitability growth. Click here to find out why NUVA is a long-term Buy.

Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical. Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical.

One of the best things about investing in high-quality real estate investment trusts ( REITs ) is that the dividends paid over time will likely increase as the company’s business and earnings grow. And as those dividends grow, the yield on your original purchase price will increase. But how does an investor know which REITs are likely to increase dividends in the future? One of the best measures is to look at companies whose dividend has been growing substantially over the previous five years and select one of those rather than a company whose dividend has remained flat or only increased slightly over time. One such company with a terrific dividend track record since 2017 is CubeSmart (NYSE: CUBE ), a Malvern, Pennsylvania-based self-storage REIT with over 1,300 storage facilities in 39 states across the U.S. CubeSmart’s 52-week price range is $36.82 to $57.34. The most recent closing price was $42.35. CubeSmart shares bolted higher this week after it was announced that it will be included in the S&P MidCap 400 Index, replacing NuVasive Inc. , which moved to the S&P …

NEW YORK, December 2, 2022: S&P Dow Jones Indices (“S&P DJI”) will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 19 to coincide with the quarterly rebalance: • Allegro Microsystems Inc. (NASD:ALGM) and CubeSmart (NYSE:CUBE) will replace Semtech Corp. (NASD: SMTC) and NuVasive Inc. (NASD: NUVA) respectively in the S&P MidCap 400. Semtech and NuVasive will replace Diversified Healthcare Trust (NASD:DHC) and Tupperware Brands Corp. (NYSE:TUP) respectively in the S&P SmallCap 600.

SAN DIEGO, Nov. 16, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate…